Authors:
SPANER D
LOWSKY R
FYLES G
LIPTON JH
BANERJEE D
NG CM
WADE JA
MESSNER HA
Citation: D. Spaner et al., ACUTE INTESTINAL GRAFT-VERSUS-HOST DISEASE IN A SYNGENEIC BONE-MARROWTRANSPLANT RECIPIENT, Transplantation, 66(9), 1998, pp. 1251-1253
Citation: Jh. Lipton et al., EXTENDED DURATION BETWEEN HARVEST AND RE-INFUSION OF HUMAN BONE-MARROW STORED AT ROOM-TEMPERATURE, Bone marrow transplantation, 20(9), 1997, pp. 785-786
Authors:
SUTHERLAND HJ
FYLES GM
ADAMS G
HAO Y
LIPTON JH
MINDEN MD
MEHARCHAND JM
ATKINS H
TEJPAR I
MESSNER HA
Citation: Hj. Sutherland et al., QUALITY-OF-LIFE FOLLOWING BONE-MARROW TRANSPLANTATION - A COMPARISON OF PATIENT REPORTS WITH POPULATION NORMS, Bone marrow transplantation, 19(11), 1997, pp. 1129-1136
Authors:
LIPTON JH
MESSNER HA
CURTIS JE
ATKINS HL
MINDEN MD
Citation: Jh. Lipton et al., INTENSIVE REMISSION INDUCTION THERAPY FOR CHRONIC MYELOID-LEUKEMIA INBLAST PHASE WITH A GOAL OF POSTREMISSION BONE-MARROW TRANSPLANT - A PILOT-STUDY, European journal of haematology, 57(1), 1996, pp. 42-45
Authors:
COUBAN S
STEWART AK
LOACH D
PANZARELLA T
MESSNER HA
KEATING A
MEHARCHAND J
Citation: S. Couban et al., AUTOLOGOUS (AUTO) AND ALLOGENEIC (ALLO) BONE-MARROW (BMT) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPCT) TRANSPLANTATION FOR MYELOMA, Blood, 88(10), 1996, pp. 2463-2463
Authors:
CHANG H
BLONDAL JA
BENCHIMOL S
MINDEN MD
MESSNER HA
Citation: H. Chang et al., P53 MUTATIONS, C-MYC AND BCL-2 REARRANGEMENTS IN HUMAN NON-HODGKINS-LYMPHOMA CELL-LINES, Leukemia & lymphoma, 19(1-2), 1995, pp. 165-171
Authors:
PHILLIPS GL
NEVILL TJ
SPINELLI JJ
NANTEL SH
KLINGEMANN HG
BARNETT MJ
SHEPHERD JD
CHAN KW
MEHARCHAND JM
SUTHERLAND HJ
REECE DE
MESSNER HA
Citation: Gl. Phillips et al., PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING UNRELATED DONOR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(2), 1995, pp. 213-219
Citation: S. Couban et al., LONG-TERM GROWTH OF BCR-ABL POSITIVE PROGENITOR CELLS FROM CNL PATIENTS IN SUSPENSION-CULTURE, Blood, 86(10), 1995, pp. 2086-2086
Authors:
REDDY VS
RAO R
LIPTON J
HAO Y
FYLES G
TEJPAR I
MINDEN MD
ATKINS H
MEHARCHAND J
MESSNER HA
Citation: Vs. Reddy et al., TOXICITY AND OUTCOME OF BUSULFAN AND CYCLOPHOSPHAMIDE PREPARATIVE REGIMEN IN BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3834-3834
Authors:
KISS TL
LIPTON JH
BERGSAGEL DE
MEHARCHAND JM
JAMAL N
MINDEN MD
MESSNER HA
Citation: Tl. Kiss et al., DETERMINATION OF IL6, IL1, AND IL4 IN THE PLASMA OF PATIENTS WITH MULTIPLE-MYELOMA, Leukemia & lymphoma, 14(3-4), 1994, pp. 335-340
Authors:
COWAN DH
MESSNER HA
JAMAL N
AYE MT
SMILEY RK
Citation: Dh. Cowan et al., SPONTANEOUS REMISSION OF POLYCYTHEMIA-VERA - CLINICAL AND CELL-CULTURE CHARACTERISTICS, American journal of hematology, 46(1), 1994, pp. 54-56
Citation: S. Gluck et al., RADIOSENSITIVITY OF HUMAN CLONOGENIC MYELOMA CELLS AND NORMAL BONE-MARROW PRECURSORS - EFFECT OF DIFFERENT DOSE-RATES AND FRACTIONATION, International journal of radiation oncology, biology, physics, 28(4), 1994, pp. 877-882
Authors:
MESSNER HA
ATKINS H
CURTIS H
FYLES G
LIPTON J
MEHARCHAND J
MINDEN MD
TEIPAR I
HAO Y
Citation: Ha. Messner et al., IMPROVEMENT OF DISEASE-FREE SURVIVAL IN BONE-MARROW TRANSPLANT RECIPIENTS WITH AML IN FIRST-CHRONIC PHASE - A REFLECTION OF IMPROVED SUPPORTIVE CARE, Experimental hematology, 22(8), 1994, pp. 692-692
Authors:
MESSNER HA
KEATING A
STEWART J
LIPTON J
CURTIS J
MINDEN MD
CRUMP M
MEHARCHAND J
Citation: Ha. Messner et al., INTERFERON IN THE MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA, Experimental hematology, 22(8), 1994, pp. 797-797
Authors:
XU WM
PIAO XH
ADDY L
JAMAL N
MINDEN MD
MESSNER HA
Citation: Wm. Xu et al., MINIMAL RESIDUAL DISEASE IN BONE-MARROW TRANSPLANT RECIPIENTS WITH CHRONIC MYELOID-LEUKEMIA, Bone marrow transplantation, 14(2), 1994, pp. 299-306
Citation: Gb. Adams et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM A RELATED DONOR UNDERGOING LONG-TERM IMMUNOSUPPRESSIVE AND CYTOTOXIC THERAPY, Bone marrow transplantation, 13(6), 1994, pp. 831-833
Authors:
LEE L
MILLER PA
MAXYMIW WG
MESSNER HA
ROTSTEIN LE
Citation: L. Lee et al., INTRAORAL PYOGENIC GRANULOMA AFTER ALLOGENIC BONE-MARROW TRANSPLANT -REPORT OF 3 CASES, Oral surgery, oral medicine, oral pathology, 78(5), 1994, pp. 607-610
Citation: Yc. Dai et al., LYMPHOMA CELL-CULTURE UNDER SERUM-FREE CONDITIONS, In vitro cellular & developmental biology. Animal, 29A(8), 1993, pp. 630-632
Authors:
ITOH T
MESSNER HA
JAMAL N
TWEEDDALE M
SIEBER F
Citation: T. Itoh et al., MEROCYANINE 540-SENSITIZED PHOTOINACTIVATION OF HIGH-GRADE NON-HODGKINS-LYMPHOMA CELLS - POTENTIAL APPLICATION IN AUTOLOGOUS BMT, Bone marrow transplantation, 12(3), 1993, pp. 191-196
Authors:
CHADWICK DE
JEAN LF
JAMAL N
MESSNER HA
MURPHY JR
MINDEN MD
Citation: De. Chadwick et al., DIFFERENTIAL SENSITIVITY OF HUMAN MYELOMA CELL-LINES AND NORMAL BONE-MARROW COLONY-FORMING CELLS TO A RECOMBINANT DIPHTHERIA-TOXIN INTERLEUKIN-6 FUSION PROTEIN, British Journal of Haematology, 85(1), 1993, pp. 25-36
Citation: Ra. Mcivor et al., AEROSOL PENTAMIDINE FOR PCP PROPHYLAXIS IN PATIENTS ALLERGIC TO TMP SMX FOLLOWING ALLOGENIC BONE-MARROW TRANSPLANTATION, The American review of respiratory disease, 147(4), 1993, pp. 404-404